A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

Name: A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
Published: 2026
License: Public Domain

GlaxoSmithKline · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

paclitaxel pembrolizumab

ovarian neoplasms, platinum-resistant ovarian cancer, mocertatug rezetecan, mo-rez, gsk5733584, paclitaxel, pembrolizumab, bevacizumab, pegylated liposomal doxorubicin (pld), topotecan, gemcitabine, antibody-drug conjugate

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 827893
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.